Bone Support

Share Price

BONEX 269.60 SEK

+1.13%

14:42:45 CET Wed Jun 25 2025

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • Reimbursement Programs
    • OPTIONAL DELIVERY DEVICES
  • Innovation
    • Current Technology
    • Pipeline
    • CERTiFy Clinical Trial
  • Indications
  • Medical Professionals
  • Investors
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Events
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Media Archive

Indications

Please choose an indication you would like to know more about.

  • All Categories
  • Septic Revision Arthroplasty
  • Aseptic Revision Arthroplasty
  • Benign Bone Tumors
  • Chronic Osteomyelitis
  • Diabetic Foot
  • Fracture-Related Infection
  • Trauma
  • Open Fracture

Open Fracture

Open Fracture
  • Case report
  • Clinical Paper
  • Video
  • Webinar

©BONESUPPORT AB 2025. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy